The unrecognized threat of PAD

2024-04-05
The unrecognized threat of PAD
Preview
来源: FiercePharma
None
This week on “The Top Line,” we explore peripheral arterial disease, a serious health issue that is often overlooked and undermanaged.
Join Editor-in-Chief of Fierce Life Sciences and Healthcare Ayla Ellison as she sits down with Kumar Madassery, M.D., Director of the Peripheral Vascular Intervention & CLI Program at Rush University Medical Center. They discuss the hidden dangers of PAD, and Dr. Madassery emphasizes the importance of early detection. He also discusses the launch of the PAD Pulse Alliance, a collaborative effort among vascular health experts aimed at raising awareness, improving early detection and reducing amputation rates.
To learn more about the topics in this episode:
Philips-supported campaign wants Americans to 'get a pulse on PAD' amid ignorance of the disease
Johnson & Johnson 'Save Legs. Change Lives.' campaign brings PAD amputation awareness to Black community
Bayer and J&J's Xarelto reduces ischemia risk for PAD patients after revascularization surgery
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。